Clinical Trials Directory

Trials / Completed

CompletedNCT03696628

Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells (DMDstem)

Modeling and Pharmacological Targeting of Genetic Cardiomyopathy in Children Via Cardiomyocytes Derived From Induced Pluripotent Stem Cells

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
0 Years – 17 Years
Healthy volunteers
Accepted

Summary

Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), "patient-specific" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin.

Detailed description

Interventional, cross-sectional biomedical study of children with genetic cardiomyopathy and healthy children. The aim is to generate, via induced human pluripotent stem cells (hiPSC), "patient-specific" cardiomyocytes (CMs) (hiPSC-CMs) to study the molecular mechanisms of cardiomyopathies of genetic origin. The study will be proposed to the parents or legal guardians of the children from 0 to 17 included sent in pediatric cardiology consultation to the University Hospital of Montpellier as part of their usual follow-up or a health check (control) . The only direct intervention performed on the patient is a venous blood sample. The volume of blood collected will be lower than the thresholds defined in the Decree of December 2nd, 2016 on minimal risks in biomedical research (3 ml).

Conditions

Interventions

TypeNameDescription
OTHERElectrocardiogramheart testing
OTHERphysical examinationdone by the investigator
OTHERechocardiographyheart testing
BIOLOGICALblood testA sample of blood will be taken to each patient or healthy children in order to generate hiPSC-cardiomyocytes

Timeline

Start date
2017-09-25
Primary completion
2021-01-20
Completion
2021-01-20
First posted
2018-10-04
Last updated
2022-12-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03696628. Inclusion in this directory is not an endorsement.